News & Events

News & Events

Latest

Gene regulatory network diagram courtesy of the MorPhiC Consoritum
Gene regulatory network diagram courtesy of the MorPhiC Consoritum
Cataloguing genes at the molecular/cellular level
The Molecular Phenotypes of Nulle Alleles in Cells (MorPhiC) Consortium aims to advance the scientific understanding of the human genome, particularly, with regard to gene function at the molecular and cellular level. Read more about the Consortium’s goals, deliverables, and implementation plans was recently published in Nature.
Computer code displayed on a laptop screen with the reflection of person on the screen
Computer code displayed on a laptop screen with the reflection of person on the screen
Tackling critical health challenges with data-driven solutions
From addressing health disparities in the Marshallese community in Washington state to analyzing trends in adolescent substance-related hospital visits, students in the University of Washington Biostatistics department’s Master of Science Capstone program have applied their knowledge and skills to help address a wide range of pressing public health challenges.
Ali Shojaie
Ali Shojaie
Ali Shojaie shares how biostatistics is key to protecting human health
Biostatistics Professor Ali Shojaie is helping us unlock the complex systems of human health thanks to innovative statistical methods.
Guanghao Qi
Guanghao Qi
Chasing genetic variants
Guanghao Qi receives a $945,000 K01 award from the NHGRI to study single-cell expression quantitative trait loci (eQTL) data, which characterizes effects of genetic variants on gene expression at the cell level.
Kevin Lin
Kevin Lin
Could certain brain cells have a ‘superpower’ that shields them from the effects of Alzheimer’s?
UW researcher Kevin Lin is part of a collaborative team developing new statistical techniques designed to account for human variability, cognitive resilience, and potential confounding factors in Alzheimer's disease. The work aims to extract meaningful insights into how certain individuals resist cognitive decline despite extensive AD pathology.